Hearing Ability in Children with Bilateral Cochlear Implants
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-005591
Sponsor Protocol Number: 14-005591
About this study
This study is being done to learn more about the development of the auditory skills in children with bilateral cochlear implants.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Children (4 to 12 years old) with bilateral cochlear implants. Children need to have received their simultaenous or sequential bilateral cochlear implants either before 12 months of age or between 12 to 36 months of age.
All children will have spoken American English as their native language.
Two groups of children (ages 4 to 12 years old): one group who was bilaterally implanted before 12 months of age and one group who was implanted between 12 to 36 months of age.
Exclusion Criteria:
Children with a diagnosis of developmental delay.
Children whos primary language is not American English.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Douglas Sladen, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available